119 related articles for article (PubMed ID: 35193833)
1. Association of Obesity and Diabetes With Prostate Cancer Risk Groups in a Multiethnic Population.
Zhu D; Toker M; Shyr W; Fram E; Watts KL; Agalliu I
Clin Genitourin Cancer; 2022 Jun; 20(3):299-299.e10. PubMed ID: 35193833
[TBL] [Abstract][Full Text] [Related]
2. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.
Fukushima H; Masuda H; Kawakami S; Ito M; Sakura M; Numao N; Koga F; Saito K; Fujii Y; Yamamoto S; Yonese J; Fukui I; Kihara K
Urology; 2012 Jun; 79(6):1329-34. PubMed ID: 22656412
[TBL] [Abstract][Full Text] [Related]
3. The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series.
Moreira DM; Anderson T; Gerber L; Thomas JA; Bañez LL; McKeever MG; Hoyo C; Grant D; Jayachandran J; Freedland SJ
Cancer Causes Control; 2011 Jul; 22(7):977-83. PubMed ID: 21562753
[TBL] [Abstract][Full Text] [Related]
4. Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database.
Wu C; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2013 Jun; 111(8):E310-8. PubMed ID: 23305170
[TBL] [Abstract][Full Text] [Related]
5. Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.
Salgado-Montilla J; Soto Salgado M; Surillo Trautmann B; Sánchez-Ortiz R; Irizarry-Ramírez M
Lipids Health Dis; 2015 Sep; 14():111. PubMed ID: 26377420
[TBL] [Abstract][Full Text] [Related]
6. Overall and central obesity and prostate cancer risk in African men.
Agalliu I; Lin WJ; Zhang JS; Jacobson JS; Rohan TE; Adusei B; Snyper NYF; Andrews C; Sidahmed E; Mensah JE; Biritwum R; Adjei AA; Okyne V; Ainuson-Quampah J; Fernandez P; Irusen H; Odiaka E; Folasire OF; Ifeoluwa MG; Aisuodionoe-Shadrach OI; Nwegbu MM; Pentz A; Chen WC; Joffe M; Neugut AI; Diallo TA; Jalloh M; Rebbeck TR; Adebiyi AO; Hsing AW
Cancer Causes Control; 2022 Feb; 33(2):223-239. PubMed ID: 34783926
[TBL] [Abstract][Full Text] [Related]
7. General and abdominal obesity trajectories across adulthood, and risk of prostate cancer: results from the PROtEuS study, Montreal, Canada.
Vallières E; Mésidor M; Roy-Gagnon MH; Richard H; Parent MÉ
Cancer Causes Control; 2021 Jun; 32(6):653-665. PubMed ID: 33818663
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity.
Tafuri A; Rizzetto R; Amigoni N; Sebben M; Shakir A; Gozzo A; Odorizzi K; Gallina S; Bianchi A; Ornaghi P; Brunelli M; Migliorini F; Cerruto MA; Artibani W; Siracusano S; Antonelli A; Porcaro AB
Urol Int; 2021; 105(5-6):362-369. PubMed ID: 33059351
[TBL] [Abstract][Full Text] [Related]
9. Higher body mass index increases the risk for biopsy-mediated detection of prostate cancer in Chinese men.
Hu MB; Bai PD; Wu YS; Zhang LM; Xu H; Na R; Jiang HW; Ding Q
PLoS One; 2015; 10(4):e0124668. PubMed ID: 25861033
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy.
Yashi M; Nukui A; Tokura Y; Takei K; Suzuki I; Sakamoto K; Yuki H; Kambara T; Betsunoh H; Abe H; Fukabori Y; Nakazato Y; Kaji Y; Kamai T
BMC Urol; 2017 Jun; 17(1):47. PubMed ID: 28645325
[TBL] [Abstract][Full Text] [Related]
11. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer.
Yamoah K; Zeigler-Johnson CM; Jeffers A; Malkowicz B; Spangler E; Park JY; Whittemore A; Rebbeck TR
BMC Cancer; 2016 Jul; 16():557. PubMed ID: 27473687
[TBL] [Abstract][Full Text] [Related]
12. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
13. Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection.
Briganti A; Karakiewicz PI; Chun FK; Suardi N; Gallina A; Abdollah F; Freschi M; Doglioni C; Rigatti P; Montorsi F
Int J Urol; 2009 Aug; 16(8):676-81. PubMed ID: 19602006
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE.
Latini DM; Chan JM; Cowan JE; Arredondo SA; Kane CJ; Penson DF; DuChane J; Carroll PR;
Urology; 2006 Dec; 68(6):1242-7. PubMed ID: 17141841
[TBL] [Abstract][Full Text] [Related]
15. The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer.
Wissing M; Chevalier S; McKercher G; Laprise C; Aprikian S; O'Flaherty A; Scarlata E; Saad F; Carmel M; Lacombe L; Brimo F; Latour M; Ekindi-Ndongo N; Têtu B; Aprikian A
World J Urol; 2019 May; 37(5):789-798. PubMed ID: 30136199
[TBL] [Abstract][Full Text] [Related]
16. Obesity and prostate cancer: weighing the evidence.
Allott EH; Masko EM; Freedland SJ
Eur Urol; 2013 May; 63(5):800-9. PubMed ID: 23219374
[TBL] [Abstract][Full Text] [Related]
17. Performance of prostate cancer recurrence nomograms by obesity status: a retrospective analysis of a radical prostatectomy cohort.
Zeigler-Johnson C; Hudson A; Glanz K; Spangler E; Morales KH
BMC Cancer; 2018 Nov; 18(1):1061. PubMed ID: 30390642
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus and prostate cancer risk.
Pierce BL; Plymate S; Ostrander EA; Stanford JL
Prostate; 2008 Jul; 68(10):1126-32. PubMed ID: 18459104
[TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
Schiffmann J; Salomon G; Tilki D; Budäus L; Karakiewicz PI; Leyh-Bannurah SR; Pompe RS; Haese A; Heinzer H; Huland H; Graefen M; Tennstedt P
Urol Oncol; 2017 May; 35(5):243-249. PubMed ID: 28161322
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy.
Oh JJ; Hong SK; Lee S; Sohn SJ; Lee SE
Int Urol Nephrol; 2013 Feb; 45(1):121-7. PubMed ID: 23054323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
